**PUBLIC RECANT** I feel all real longs have shown great

New Post Public Reply Private Reply Replies (3) Message Board
NickAidenNY NickAidenNY #48238
597
**PUBLIC RECANT**

I feel all real longs have shown great fortitude, resilience and ultimate faith and because of this you will be rewarded greatly.

Being a retail investor in IPIX for over 5 years, you see the good and the bad and everything in between. I have seen the good in people and I've seen the very bad. I've even been attacked by longs for giving my opinions although I never directly bashed the company. I've been called a multi-identity, have had legitimate posts deleted and been attacked through direct messaging because I give my insights and my trepidation accordingly. I have always believed that management had good intentions and I always believed in the SCIENCE.

The one thing I could never understand was why management would create the milestone payments to Aspire from June 30th to Sept 30th and further dilute us with 16 million shares that I described as "toxic" funding if a real partnership was on the horizon. It made me wonder, although I had unwavering faith, if something may be going on with management or if we may have been milked. If you are a long and didn't have this feeling at least once then I think you would be lying... The 5% in me that questioned the situation as my "Alternative Scenario" in the previous post WAS DEAD WRONG...

The 10k proves this beyond doubt. Most people see this 10k as doom and gloom, but it's not. It's management preparing for a very bright, lucrative future for a company that has had a target on its back and will have a LARGER target once, what we all know is being worked on, comes to fruition. Here are my opinions, take them or leave them. I am very impressed by Leo and management from taking this company from a glimmer to a supernova before it's last contracting blast.

Aspire was necessary... They were even more necessary once the attacks came from Mako, the frivolous lawsuit, and the band of gutless spewing aliases among the boards.

Aspire became much more useful when management became super aware that they had struck pharmaceutical oil. You should be proud of your management. They bought assets from bankruptcy proceedings and made your investment into a gold mine. The milestone agreement was put in place along with the manufacturing contracts because management understood that any potential partner would low ball the assets because of the overall inconsistency and uncertainty. Leo used the Aspire contingency plan to gain leverage and that's exactly what is occurring. He has a term sheet for B-OM and I have reason to believe Prurisol delay is not purely on accident or mismanagement of funding. This was a calculated delay which gave the ability to add B-IBD to the partnership. Prurisol will be a success and management's keen intuition will allow for this soon. You may be upset we haven't gotten the results but trust me when I say it will pay off in dividends with a little patience.

The 10k proved what I am speaking of with Note 13 and the other expenses loss since there is high probability of not reaching the milestones by September 30th. Why announce the milestones if they are not needed any longer? Why further dilute shares to loyal share holders with what's down the pike? I believe Aspire is not happy about this. They can dump shares and the market manipulators, we have all come to know and love, can speak countless hours of doom to clear their short interest from both Aspire and retail. Don't let it happen! Swallow up shares while you can.

The 10k was management's last attempt to shield themselves from libelous commentary, short interest manipulators and frivolous lawsuits right before the REAL PRESS starts to hit. IPIX will be the darling of the town but it will create even further manipulators to start licking their chops... The 10k spells this out knowing that the REAL LONGS will hold their ground. Leo and Menon have a lot of skin the game. Count their salaries all you may but they WILL show you finally that they are worth every damn red cent they make and more. They deserve the generational wealth to come for them as they will provide great drugs to needy people, including my mother, while staying out of debt and maximizing shareholder's interests.

The 10k was EXACTLY what I wanted to see.

Yes, share price and market cap have taken a hit but like I said previously, it has absolutely no bearing to what the assets are worth or what a worldwide pharma will be willing to pay to partner for them.

There is always risk... This was SPELLED out to you completely in the 10k but I am MORE confident then I have ever been regardless of what my Ameritrade account says!

I made a mistake questioning management. The OTC sucks and hopefully we will rid ourselves of the exchange. Hopefully the cast of characters will jump to the next company but I say this with regret. It's unfortunate they use their tactics for financial gain by attacking companies looking to better the world and utilize capitalism for its best standards of reward.

I am humbled... I thought I was the smartest in the room but I said that while Leo was in the room with me... I appreciate everything he has accomplished to date and I am behind you 100%.

There were many great posts from very informed people on all boards. I would like to thank them all for their insight. One in particular has kept me going as of recent. For that I appreciate you. I hope the people who continually bash this company and management (even antisemitism) finally get their day of reckoning as Financial Murphy's Law swings the pendulum towards your tuckus.

GO IPIX, GO LEO, GO MENON, GO LONGS!

1

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 5

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 7

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 5

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 4

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 6

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 4

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 2

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading

Top 5 Most Recently Viewed Articles

IGT Enhances Sports Betting Experience at Golden Nugget Casinos

Updated Category News Views 119

IGT PlaySports Reinforces Position in Sports Betting Market International Game Technology PLC (NYSE: IGT) has taken a significant step in expanding its sports betting operations. This move comes through a strategic agreement with GN NV Holdings, LLC, the parent company of the renowned Golden Nugget Casinos. This partnership aims to enhance the sports betting experience...

Continue Reading
Globe Telecom Sets New Industry Standards for Sustainability

Updated Category News Views 435

Globe Telecom Sets New Industry Standards for Sustainability Globe has achieved remarkable recognition for its commitment to sustainability in the telecommunications sector. Winning the Standard Insights' Consumer Choice Awards highlights Globe's dedication to establishing the most sustainable telecommunications network and leading the charge for environmental stewardship...

Continue Reading
Dueling Tesla Analysts: Ives Goes Bold with Robotaxis, Black Cautious

Updated Category News Views 102

A Tale of Two Tesla Analysts The electric vehicle realm has always been tumultuous, but the contrast between two prominent analysts regarding Tesla Inc. (NASDAQ: TSLA) brings a new level of intrigue. Dan Ives and Gary Black recently showcased their differing views during a recent appearance, reflecting both optimism and caution for Tesla's future in a rapidly evolving...

Continue Reading
PharmaSentinel and Pay10 Forge Partnership for Medsii.com

Updated Category News Views 144

PharmaSentinel and Pay10 Join Forces In an exciting development for the digital health sector, PharmaSentinel Limited, a trailblazer in AI-driven health solutions, has formed a significant license agreement with Pay10. This partnership is centered around Medsii.com, an innovative platform aimed at enhancing pharmaceutical insights to help users navigate the complexities...

Continue Reading
L’Oréal's 2025 Half-Year Results Show Strong Growth Trends

Updated Category News Views 1942

Strong Performance Highlights from L’Oréal's 2025 Half-Year Results As L’Oréal continues to set benchmarks in the beauty industry, its half-year results for 2025 unveil a remarkable story of growth and resilience. With sales hitting an impressive €22.47 billion, a 3.0% increase in like-for-like terms, the group demonstrates its solid operational strategy and...

Continue Reading